Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Sunday, December 6, 2009, 2:03AM ET - U.S. Markets Closed. Dow Up 0.22% Nasdaq Up 0.98%
Exact Sciences Corporation (EXAS)On Dec 4: 2.64  Up 0.05 (1.93%)  
MORE ON EXAS
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Exact Sciences Corporation
441 Charmany Drive
Madison, WI 53719
United States - Map
Phone: 608-284-5700
Fax: 608-284-5701
Web Site: http://www.exactsciences.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:4

BUSINESS SUMMARY 
Exact Sciences Corporation, a molecular diagnostics company, focuses on the early detection and prevention of colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Its non-invasive stool-based DNA (sDNA) screening technology includes proprietary and patented methods that isolate and analyze human DNA present in stool to screen for the presence of colorectal pre-cancer and cancer. The company’s principal product includes ColoSure, a non-invasive laboratory developed stool-based DNA testing service for the detection of colorectal cancer in the average-risk population. Exact Sciences Corporation has strategic alliances with Laboratory Corporation of America Holdings, the MAYO Foundation for Medical Education and Research, and Genzyme Corporation. The company was founded in 1995 and is based in Madison, Wisconsin.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Exact Sciences Corporation


    CORPORATE GOVERNANCE 
    Exact Sciences Corporation's Corporate Governance Quotient (CGQ®) as of 1-Dec-09 is better than 77.2% of CGQ Universe companies and 53.7% of Pharmaceuticals, Biotechnology & Life Sciences companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. Patrick J. Zenner MBA, 61
    Exec. Chairman and Member of Compensation Committee
    $ 7.00KN/A
    Mr. Kevin T. Conroy , 43
    Chief Exec. Officer, Pres
    N/A N/A
    Mr. Maneesh K. Arora , 40
    Chief Financial Officer and Sr. VP
    N/A N/A
    Dr. Barry M. Berger M.D., FCAP,
    Chief Medical Officer
    N/A N/A
    Dr. Graham P. Lidgard Ph.D., 59
    Chief Science Officer and Sr. VP
    N/A N/A
    Dollar amounts are as of 31-Dec-07 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis